Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling

Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients

(2013) Liesbeth Hameetman et al.   BMC CANCER

Evaluation of AJCC Tumor Staging for Cutaneous Squamous Cell Carcinoma and a Proposed Alternative Tumor Staging System

(2013) Anokhi Jambusaria-Pahlajani et al.   JAMA Dermatology

A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22-Year Prospective Study in an Ethnically Diverse Population

(2012) C. A. Harwood et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma

(2012) J. G. Einspahr et al.   Cancer Prevention Research

Regulation of p53 Stability and Apoptosis by a ROR Agonist

(2012) Yongjun Wang et al.   PLoS One

Skin Tumors Induced by Sorafenib; Paradoxic RAS-RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1

(2011) J. P. Arnault et al.   CLINICAL CANCER RESEARCH

Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene

(2011) Sally R. Lambert et al.   INTERNATIONAL JOURNAL OF CANCER

BRAF targeted therapy changes the treatment paradigm in melanoma

(2011) Antoni Ribas et al.   Nature Reviews Clinical Oncology

Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma

(2011) N. J. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer

(2011) Po Yee Yip et al.   PROSTATE

Temporal Dissection of Tumorigenesis in Primary Cancers

(2011) Steffen Durinck et al.   Cancer Discovery

Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006

(2010) Howard W. Rogers et al.   ARCHIVES OF DERMATOLOGY

Gene Expression Patterns of Normal Human Skin, Actinic Keratosis, and Squamous Cell Carcinoma

(2010) R. Steven Padilla et al.   ARCHIVES OF DERMATOLOGY

Efficacy of c-Met inhibitor for advanced prostate cancer

(2010) William H Tu et al.   BMC CANCER

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

(2010) Sonja J. Heidorn et al.   CELL

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

Non-melanoma skin cancer

(2010) Vishal Madan et al.   LANCET

Differential expression of NF-κB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism

(2010) R A Hamoudi et al.   LEUKEMIA

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

(2010) Poulikos I. Poulikakos et al.   NATURE

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

(2010) Georgia Hatzivassiliou et al.   NATURE

Systematic comparison of nonmelanoma skin cancer microarray datasets reveals lack of consensus genes

(2009) R. Van Haren et al.   BRITISH JOURNAL OF DERMATOLOGY

Actinic keratoses

(2009) Vincent D. Criscione et al.   CANCER

Cutaneous head and neck SCCs and risk of nodal metastasis – UK experience

(2009) Constantinos Mourouzis et al.   JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY

Single Nucleotide Polymorphism Array Analysis Defines a Specific Genetic Fingerprint for Well-Differentiated Cutaneous SCCs

(2009) Karin J. Purdie et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The autocrine human secreted PDZ domain-containing protein 2 (sPDZD2) induces senescence or quiescence of prostate, breast and liver cancer cells via transcriptional activation of p53

(2008) Chun Wai Tam et al.   CANCER LETTERS